Contributor Page
Haug Partners
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 588 0800
Fax: +1 212 588 0500
745 Fifth Avenue, Floor 10
New York
NY 10151
United States
By David Shotlander
For many companies that compete in competitive markets, innovation and product improvement fuels competitive success: create a better product than your competitors, and over time, make it better.
By David Zwally, Michelle Irwin
On January 12, 2017, the Federal Circuit decided Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., providing its first opinion on divided infringement for pharmaceutical method patents under...
By Edgar Haug
Co-Founder and Managing Partner, Ed Haug, spoke to LEADERS Magazine about the firm's expansions of services which include: commercial litigation and strategic counseling; due diligence...
By Richard Kurz, Alexander Callo
On May 1, 2017, the U.S. Court of Appeals for the Federal Circuit issued an opinion in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. that considered the America Invents Act...
By Richard Kurz, Alexander Callo
In a recent opinion, Mentor Graphics Corp. v. EVE-USA Inc., No. 15-1470 (Fed. Cir. Mar. 16, 2017), the Federal Circuit evaluated when a patentee is entitled to lost profit damages.
By David Shotlander
For many companies that compete in competitive markets, innovation and product improvement fuels competitive success: create a better product than your competitors, and over time, make it better.
By David Zwally, Michelle Irwin
On January 12, 2017, the Federal Circuit decided Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., providing its first opinion on divided infringement for pharmaceutical method patents...
By Edgar Haug, Angus Chen, Jason Lief, Elizabeth Murphy, Andrew Wasson, Michelle Irwin, Jason Kanter, Erika Selli, Camille Turner, Janice Ye
Shire Pharmaceuticals has just achieved another victory in the enforcement of its Lialda® patent.
By Kyle Haug, Nicholas Giove, Laura Chubb, Jonathan Herstoff, Andrew Roper, Damon Lewis, Camille Turner
Following a December 8, 2016 oral argument, the United States Court of Appeals for the Federal Circuit entered a Rule 36 judgment on December 12, 2016...
By Bryan Braunel
Section 289 provides that a design patent owner can recover an infringer's "total profit" as damages for the sale of "any article of manufacture to which such design … has been applied...
By Joseph Saphia, Bonnie Gaudette
The Federal Circuit, for only the third time since the Supreme Court provided the two-step Alice framework in 2014, found software-based patent claims eligible under step two of the analysis.
By David Shotlander
On October 20, 2016, the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission ("the agencies") jointly issued Antitrust Guidance for Human Resources Professionals.
By Nicholas Giove
The Federal Circuit's decision on October 20, 2016 in Medtronic Inc. v. Robert Bosch Healthcare Systems reaffirms that it lacks the authority to review PTAB vacaturs of PTAB institution decisions in IPRs.
By Caroline Bercier
The United States Patent and Trademark Office ("PTO") published a proposed rule in the Federal Register on October 18, 2016...
By Haug Partners
The District of New Jersey entered a Final Judgment ending a Hatch-Waxman patent infringement lawsuit and protecting innovator pharmaceutical company Shire's blockbuster drug Vyvanse® (lisdexamfetamine dimesylate).